|
Hernandez-Caselles T, Miguel RC, Ruiz-Alcaraz AJ, Garcia-Penarrubia P. CD33 (Siglec-3) Inhibitory Function: Role in the NKG2D/DAP10 Activating Pathway. J Immunol Res. 2019 Apr 15;2019:6032141. doi: 10.1155/2019/6032141. eCollection 2019. PubMed PMID: 31143782; PubMed Central PMCID: PMC6501159.
AÑO: 2019; IF: 3.327
|
31143782
|
Altassan R, Peanne R, Jaeken J, Barone R, Bidet M, Borgel D, Brasil S, Cassiman D, Cechova A, Coman D, Corral J, Correia J, de la Morena-Barrio ME, de Lonlay P, Dos Reis V, Ferreira CR, Fiumara A, Francisco R, Freeze H, Funke S, Gardeitchik T, Gert M, Girad M, Giros M, Grunewald S, Hernandez-Caselles T, Honzik T, Hutter M, Krasnewich D, Lam C, Lee J, Lefeber D, Marques-de-Silva D, Martinez AF, Moravej H, Ounap K, Pascoal C, Pascreau T, Patterson M, Quelhas D, Raymond K, Sarkhail P, Schiff M, Seroczynska M, Serrano M, Seta N, Sykut-Cegielska J, Thiel C, Tort F, Vals MA, Videira P, Witters P, Zeevaert R, Morava E. International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up. J Inherit Metab Dis. 2019 Jan;42(1):5-28. doi: 10.1002/jimd.12024. Erratum In: J Inherit Metab Dis. 2019 May;42(3):577. PubMed PMID: 30740725.
AÑO: 2019; IF: 4.036
|
|
García-López R, de la Morena-Barrio ME, Alsina L, Pérez-Dueñas B, Jaeken J, Serrano M, Casado M, Hernández-Caselles T. Correction: Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG). PLoS One. 2016 Oct 27;11(10):e0165901. doi: 10.1371/journal.pone.0165901. eCollection 2016. PubMed PMID: 27788260; PubMed Central PMCID: PMC5082832.
AÑO: 2016; IF: 2.806
|
|
García-López R, de la Morena-Barrio ME, Alsina L, Pérez-Dueñas B, Jaeken J, Serrano M, Casado M, Hernández-Caselles T. Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG). PLoS One. 2016 Jul 14;11(7):e0158863. doi: 10.1371/journal.pone.0158863. eCollection 2016. Erratum in: PLoS One. 2016 Oct 27;11(10 ):e0165901. PubMed PMID: 27415628; PubMed Central PMCID: PMC4944953.
AÑO: 2016; IF: 2.806
|
|
Ruiz-Alcaraz AJ, Tapia-Abellán A, Fernández-Fernández MD, Tristán-Manzano M, Hernández-Caselles T, Sánchez-Velasco E, Miras-López M, Martínez-Esparza M, García-Peñarrubia P. A novel CD14(high) CD16(high) subset of peritoneal macrophages from cirrhotic patients is associated to an increased response to LPS. Mol Immunol. 2016 Apr;72:28-36. doi: 10.1016/j.molimm.2016.02.012. Epub 2016 Mar 1. PubMed PMID: 26938502.
AÑO: 2016; IF: 3.236
|